Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 11, 2018
Previous Article Next Article

Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Author affiliations

Abstract

BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This review discusses the recent advances in the design and/or modifications of BODIPYs since 2013, to improve their potential in photodynamic cancer therapy and related areas.

Graphical abstract: Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Back to tab navigation

Publication details

The article was received on 18 Mar 2018, accepted on 11 May 2018 and first published on 14 May 2018


Article type: Perspective
DOI: 10.1039/C8PP00113H
Photochem. Photobiol. Sci., 2018,17, 1691-1708

  •   Request permissions

    Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

    C. S. Kue, S. Y. Ng, S. H. Voon, A. Kamkaew, L. Y. Chung, L. V. Kiew and H. B. Lee, Photochem. Photobiol. Sci., 2018, 17, 1691
    DOI: 10.1039/C8PP00113H

Search articles by author

Spotlight

Advertisements